MedTrace Logo

Neuromodulation of Lidocaine Cream Effect on Chronic Pain Patients

NCT03046017 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-01-03

No results posted yet for this study

Summary

Chronic low back pain patients aged 21 to 60 needed for a research study of the effects of transcranial direct current stimulation (tDCS) on the analgesic effects of lidocaine cream as measured by functional Magnetic Resonance Imaging (fMRI). Study will be conducted on nine separate days not requiring an overnight stay in the hospital.

Conditions

  • Chronic Low Back Pain

Interventions

DEVICE

tDCS

Electrical stimulation will be applied on the head to temporarily influence brain activity in specific regions.

OTHER

Lidocaine cream

Lidocaine cream will be applied to reduce pain sensitivity (analgesia).

OTHER

Control cream

A neutral cream will be applied as a control.

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046017 on ClinicalTrials.gov